Not applicableLooking for participantsNCT05847166What this trial is testingA Phase 2/3,PSMA-T4, Prostate CancerWho this might be right forProstate Cancer NCBJ Polatom: Narodowe Centrum Badań Jądrowych Polatom 80
Testing effectiveness (Phase 2)Ended earlyNCT04635059What this trial is testingPacritinib for Biochemical Relapse After Definitive Treatment for Prostate CancerWho this might be right forProstate Cancer Medical College of Wisconsin 6
Not applicableLooking for participantsNCT05710861What this trial is testingCost-utility of Focal HIFU vs ProstatectomyWho this might be right forProstate Cancer University Hospital, Bordeaux 346
Not applicableActive Not RecruitingNCT02914873What this trial is testingSPCG17: Prostate Cancer Active Surveillance Trigger TrialWho this might be right forProstate Cancer Uppsala University 2,008
Not applicableStudy completedNCT01858441What this trial is testingPharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone AcetateWho this might be right forPharmacogenetic Study Centre Antoine Lacassagne 148
Large-scale testing (Phase 3)UnknownNCT01224405What this trial is testingProstate Cancer, Androgen Deprivation Withdrawal and Intermittent ChemotherapyWho this might be right forAdvanced Prostate Cancer University of Turin, Italy 600
Not applicableUnknownNCT05740488What this trial is testingEfficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone MetastasesWho this might be right forProstate Cancer With ≤10 Bone Metastases Zhujiang Hospital 30
Not applicableTemporarily pausedNCT04808427What this trial is testingPilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate CancerWho this might be right forProstate Cancer National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT00635856What this trial is testingOpen Label Trial to Assess Iressa in Prostate Cancer PatientsWho this might be right forProstate Cancer AstraZeneca 100
Not applicableLooking for participantsNCT03237702What this trial is testingDecipher Lethal Prostate Cancer Biology - Urine MetabolomicsWho this might be right forSignificant Prostate Cancer National Taiwan University Hospital 2,000
Testing effectiveness (Phase 2)WithdrawnNCT06765902What this trial is testingImmunotherapy Before and After SurgeryWho this might be right forHigh-risk Prostate Cancer ImmunityBio, Inc.
Testing effectiveness (Phase 2)Study completedNCT00030602What this trial is testingVaccine Therapy in Treating Patients With Recurrent Prostate CancerWho this might be right forProstate Cancer University of Maryland, Baltimore
Early research (Phase 1)Study completedNCT02215096What this trial is testingDose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate CancerWho this might be right forNeoplasms GlaxoSmithKline 37
Not applicableLooking for participantsNCT07820566What this trial is testingDevelopment of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers)Who this might be right forKidney CancersBladder CancerProstate Cancer University Hospital, Strasbourg, France 100
Not applicableNot Yet RecruitingNCT06435702What this trial is testingEfficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort StudyWho this might be right forProstate Cancer Peking University Third Hospital 108
Not applicableUnknownNCT00758173What this trial is testingStudy of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United KingdomWho this might be right forProstate Cancer Cancer Research UK 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT07025369What this trial is testingAndrogen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA TrialWho this might be right forProstate AdenocarcinomaStage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8+1 more Mayo Clinic 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04253483What this trial is testingComparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate CancerWho this might be right forStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8+2 more Rutgers, The State University of New Jersey 14
Not applicableLooking for participantsNCT06866041What this trial is testingBiological Markers and Advanced Imaging for Prostate Cancer Progression in Active SurveillanceWho this might be right forLow-Risk Prostate Cancer Università Vita-Salute San Raffaele 74
Large-scale testing (Phase 3)Study completedNCT00048841What this trial is testingPrevention of Osteoporosis in Men With Prostate CancerWho this might be right forProstate CancerOsteoporosisHypogonadism National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 112